Release Date: December 23, 2025
Expiration Date: December 23, 2026
Activity Overview
Given its complex presentation, Gaucher disease—a rare lysosomal storage disease with varying consequences across its subtypes—is frequently misdiagnosed or diagnosed with delay. In this program, a hematologist provides an overview of recent guidelines and expert recommendations on the diagnosis of Gaucher disease and its management with enzyme replacement and substrate reduction therapy, with a particular focus on type 1 disease.
Target Audience
Hematologists, geneticists, Gaucher specialists, orthopedists, specialty advanced practice providers, and primary care providers.
Learning Objectives
Upon successful completion of this activity, you should be better prepared to:
- Outline diagnostic criteria to identify patients with Gaucher disease
- Assess the latest efficacy and safety data for current treatments for Gaucher disease
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here